Cargando…

Design of Montelukast Nanocrystalline Suspension for Parenteral Prolonged Delivery

BACKGROUND: Montelukast (MTK), a representative leukotriene receptor antagonist, is currently being investigated as a potential candidate for treating Alzheimer’s disease. For potent and effective dosing in elderly patients, a parenteral prolonged delivery system is favored, with improved medication...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jun Soo, Kim, Min Seop, Joung, Min Yeong, Park, Hyun Jin, Ho, Myoung-Jin, Choi, Jun Hyuk, Seo, Jae Hee, Song, Woo Heon, Choi, Young Wook, Lee, Sangkil, Choi, Yong Seok, Kang, Myung Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423109/
https://www.ncbi.nlm.nih.gov/pubmed/36046838
http://dx.doi.org/10.2147/IJN.S375888